Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 2 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Stomatitis 1 Sexual Dysfunction, Physiological 1 Pruritus 1 Prostatic Neoplasms 1 Pneumonia 1 Pain 1 Nevus, Pigmented 1 Mucositis 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Leiomyoma 1 Kidney Neoplasms 1 Ileus 1 Head and Neck Neoplasms 1 Feeding and Eating Disorders 1

Interventions

Morphine 7 Fentanyl 5 Radiotherapy 4 Methadone 4 Zoledronic Acid 3 Tapentadol 2 Ropivacaine 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Cryotherapy 2 Cryosurgery 2 Bupivacaine 2 Acupuncture Therapy 2 Acetaminophen 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain × Lidocaine × Clear all

NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated

Feeding and Eating Disorders, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡